ANHEUSER-BUSCH INBEV SA/NV - Anheuser-Busch InBev reports Third Quarter 2021 Results

Anheuser-Busch InBev reports Third Quarter 2021 Results

Anheuser-Busch InBev SA/NV
(Incorporated in the Kingdom of Belgium)
Register of Companies Number: 0417.497.106
Euronext Brussels Share Code: ABI
Mexican Stock Exchange Share Code: ANB
NYSE ADS Code: BUD
JSE Share Code: ANH
ISIN: BE0974293251
(“AB InBev” or the “Company”)

Anheuser-Busch InBev reports Third Quarter 2021 Results

KEY FIGURES

•     Total Volume: In 3Q21, total volumes grew by 3.4%, with own beer volumes up by 2.8% and non-beer volumes up
      by 7.8%. In 9M21, total volumes grew by 11.9% with own beer volumes up by 12.1% and non-beer volumes up by
      10.7%.

•     Total Revenue: In 3Q21, revenue grew by 7.9% with revenue per hl growth of 4.3%. In 9M21, revenue grew by
      17.0% with revenue per hl growth of 4.7%.

•     Global Brands Revenue: In 3Q21, combined revenues of our three global brands, Budweiser, Stella Artois and
      Corona, increased by 5.0% globally and by 9.3% outside of their respective home markets. In 9M21, the combined
      revenues of our global brands increased by 18.0% globally and by 22.7% outside of their respective home markets.

•     Normalized EBITDA: Normalized EBITDA increased by 3.0% in 3Q21 and by 14.5% in 9M21. Normalized EBITDA
      margin was 36.5% in 3Q21 and 35.7% in 9M21. The 9M21 Normalized EBITDA figures include an impact of 226
      million USD from tax credits in Brazil. For more details, please see page 11 of the full announcement.

•     Underlying Profit: Underlying profit (normalized profit attributable to equity holders of AB InBev excluding mark-
      to-market gains and losses linked to the hedging of our share-based payment programs and the impact of
      hyperinflation) was 1 699 million USD in 3Q21 compared to 1 601 million USD in 3Q20 and was 4 290 million USD
      in 9M21 compared to 3 407 million USD in 9M20. Normalized profit attributable to equity holders of AB InBev was
      1 002 million USD in 3Q21 versus 1 578 million USD in 3Q20 and 3 926 million USD in 9M21 versus 1 654 million
      USD in 9M20.

•     Underlying EPS: Underlying EPS (Normalized EPS excluding mark-to-market gains and losses linked to the hedging
      of our share-based payment programs and the impact of hyperinflation) was 0.85 USD in 3Q21, an increase from
      0.80 USD in 3Q20 and was 2.14 USD in 9M21, an increase from 1.71 USD in 9M20. Normalized EPS in 3Q21 was
      0.50 USD, a decrease from 0.79 USD in 3Q20. Normalized EPS in 9M21 was 1.96 USD, an increase from 0.83 USD
      in 9M20.

2021 OUTLOOK

(i)   Overall Performance: We expect our EBITDA to grow between 10-12% and our revenue to grow ahead of EBITDA
      from a healthy combination of volume and price. The outlook for FY21 reflects our current assessment of the scale
      and magnitude of the COVID-19 pandemic, which is subject to change as we continue to monitor ongoing
      developments.

(ii)  Net Finance Costs: We expect the average gross debt coupon in FY21 to be approximately 4.0%. Net pension
      interest expenses and accretion expenses including IFRS 16 adjustments (lease reporting) are expected to be in
      the range of 140 to 160 million USD per quarter, depending on currency fluctuations. Net finance costs will
      continue to be impacted by any gains and losses related to the hedging of our share-based payment programs.

(iii) Effective Tax Rates (ETR): We expect the normalized ETR in FY21 to be in the range of 28% to 30%, excluding any
      gains and losses relating to the hedging of our share-based payment programs. The increase versus 2020 is due to
      factors including the phasing out of temporary COVID-19 measures and changes to tax attributes in some key
      markets. The ETR outlook does not consider the impact of potential future changes in legislation.

(iv)  Net Capital Expenditure: We expect net capital expenditure of between 4.5 and 5.0 billion USD in FY21 as we are
      increasing investments in innovation and other consumer-centric initiatives to fuel our momentum.

(v)   Debt: Approximately 48% of our gross debt is denominated in currencies other than the US dollar, primarily the
      Euro. Our optimal capital structure remains a net debt to EBITDA ratio of around 2x.

SHORT FORM ANNOUNCEMENT

This short-form announcement is the responsibility of the board of directors of AB InBev and is a summary of the
information in the detailed financial results announcement and does not contain full or complete details. Any
investment decision in relation to the Company’s shares should be based on the full announcement.

The full announcement may be downloaded from
https://senspdf.jse.co.za/documents/2021/jse/isse/anhe/Q32021.pdf

or from the Company’s website at www.ab-inbev.com

Copies may be requested, at no charge, from the Company’s JSE Sponsor by emailing sponsor@questco.co.za during
business hours for a period of 30 calendar days following the date of this announcement.


28 October 2021
JSE Sponsor: Questco Corporate Advisory Proprietary Limited

Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings
on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on
the New York Stock Exchange (NYSE: BUD).

Date: 28-10-2021 08:34:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.